Filter
2480
Text search:
regulatory
control
Featured
Recommendations
219
New Publications
650
Language
Document type
No document type
1145
Studies & Reports
471
Guidelines
429
Manuals
171
Strategic & Response Plan
145
Fact sheets
61
Training Material
22
Situation Updates
21
Resource Platforms
6
Brochures
4
Infographics
2
Online Courses
2
Countries / Regions
Global
114
Kenya
93
India
76
Ethiopia
54
Nigeria
52
Sierra Leone
48
South Africa
47
Western and Central Europe
47
Uganda
44
Ghana
42
Liberia
41
Africa
41
Latin America and the Carribbean
40
Zambia
36
Tanzania
33
Bangladesh
32
Nepal
30
Namibia
30
Myanmar / Burma
28
Malawi
25
Ukraine
25
Rwanda
24
East and Southern Africa
24
South–East Asia Region
24
West and Central Africa
23
Philippines
21
Syria
20
Eastern Europe
19
Middle East and North Africa
18
Lesotho
17
Guinea
13
Zimbabwe
13
Cambodia
12
Eastern Europe and Central Asia
11
Botswana
10
Asia
10
Congo, Democratic Republic of
9
South Sudan
9
Mozambique
9
Eswatini/ Swaziland
9
Western Pacific Region
8
Pakistan
7
Indonesia
7
Senegal
6
USA
6
Cameroon
6
Yemen
6
Russia
6
North America
6
Sudan
5
Moldova
5
Burkina Faso
4
Haiti
4
Somalia
4
Jordan
4
Thailand
4
Albania
4
Tajikistan
4
Georgia
4
Afghanistan
3
Germany
3
Chad
3
Benin
3
Brazil
3
Ecuador
3
Angola
3
Laos
3
United Kingdom
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Lebanon
2
Papua New Guinea
2
Central African Republic
2
Argentina
2
North Macedonia
2
Colombia
2
Paraguay
2
Timor Leste/ East Timor
2
Iran
2
Kazakhstan
2
Vietnam
2
Turkmenistan
2
Spain
2
Bosnia and Herzegovina
2
Mali
1
Morocco
1
Togo
1
Iraq
1
Turkey
1
Egypt
1
Gambia
1
China
1
Peru
1
Burundi
1
Bolivia
1
Greece
1
Libya
1
Madagascar
1
Sri Lanka
1
Chile
1
Fiji
1
Bhutan
1
Venezuela
1
Palestine
1
Qatar
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
903
Clinical Guidelines
176
Public Health
162
Key Resources
141
Women & Child Health
86
Pharmacy & Technologies
66
Capacity Building
27
Toolboxes
COVID-19
216
HIV
173
AMR
171
TB
128
Pharmacy
117
Planetary Health
104
Mental Health
103
Caregiver
81
NTDs
65
Rapid Response
58
NCDs
56
Ebola & Marburg
51
Malaria
50
Global Health Education
41
Conflict
39
Health Financing Toolbox
36
Specific Hazards
32
2.0 Rapid Response
30
Refugee
28
Disability
27
Natural Hazards
19
Zika
17
Polio
16
Cholera
8
Social Ethics
6
Achieving Quality Health Care in Bangladesh:
2014 Bangladesh Health Facility Survey (BHFS)
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid
...
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
In the last three decades, health financialization has surged in
several creative ways, yet this growing phenomenon remains surprisingly
unknown, and neglected, in the global health arena. Financialization in the
health domain could be described as the uncontrolled expansion of finance along vari
...
The key tools and governance approaches for
international cooperation for sustainable development
(hereafter, international cooperation) were set up in a
markedly different time and age. International
cooperation – with official development assistance
(ODA) as the dominant means of implementa
...
Achieving financial risk protection for the whole population requires significant financing for health. Health systems in low- and middle-income countries (LMIC) are plagued with persistent underfunding, and recent reductions in official development assistance have been registered. To create fiscal
...
Development assistance for health (DAH)
plays a vital role in supporting health programmes in lowand middle-income countries. While DAH has historically
focused on infectious diseases and maternal and child
health, there is a lack of comprehensive analysis of DAH
trends, strategic shifts and the
...
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t
...
This comprehensive HPFM report thoroughly explores Kenya’s health financing landscape. It provides an in-depth analysis of the current state of affairs and sheds light on required strategic changes in health financing. The report points out the need to improve public financial management within th
...
For this report, the Task Force commissioned
additional background papers on health taxes to
update the evidence, assess short-term revenue
potential, and understand the role of health taxes
in the current era of multiple crises. We find that
health taxes continue to be underutilized despite th
...
This Guide is part of WHO’s overall programme of work on Political Economy of Health Financing Reform: Analysis and Strategy to Support UHC. The impetus for this work came from demands for more concrete evidence, recognition and integration of political economy issues within
health financing, and
...
In 2022, Namibia had an estimated population of 2.6 million people, where 51 per cent per cent are females and 52.5 per cent of households in urban areas, with fast-growing urban informal settlements which lack access to basic services. Namibia has a young population; 42 per cent are children (0-17
...
The Regional Child Protection Operational Note has been developed by IOM and UNICEF’s Regional and Country Offices in North, West and Central Africa as a collaborative inter-agency and cross-regional endeavour within the framework of the sixth phase of the IOM Regional Development and Protection P
...
Meeting report, Kampala, Uganda,
7–8 November 2023
Two malaria vaccines are currently WHO prequalified and recommended1 for use to prevent
P. falciparum malaria in young children, the RTS,S/AS01 vaccine, currently manufactured by
GlaxoSmithKline (GSK), and the R21/Matrix-M vaccine, manufactured by Serum Institute of India
Pvt (SII)
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN
...
